Zymeworks BC Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 5 rows in 2022. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2022-07-18: Reporting owner Moore Paul Andrew; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2022-03-10: Reporting owner Astle Christopher; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2022-03-10: Reporting owner Klompas Neil A; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2022-03-04: Reporting owner Astle Christopher; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2022-07-18 | Moore Paul Andrew Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $5.82 exercise price | 2022-07-19 | |
| 2022-03-10 | Astle Christopher Officer (SVP & Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +125,000 125,000 owned after | $7.00 exercise price | 2022-03-11 | |
| 2022-03-10 | Klompas Neil A Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $7.00 exercise price | 2022-03-11 | |
| 2022-03-04 holding as of filing | Astle Christopher Officer (SVP & Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $29.81 exercise price | 2022-03-04 | ||
| 2022-01-15 | Galbraith Kenneth Director, Officer (Chair, President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +500,000 500,000 owned after | $14.97 exercise price | 2022-01-18 |